Showing 41 - 60 of 774 results
An international collaboration of researchers has used ANSTO's facilities to find something new about the properties one of the most fundamental everyday materials, water, and answered an important scientific question.
Our people, the custodians of Australia’s nuclear and accelerator expertise, are amongst our nation’s most talented researchers, scientists, engineers and nuclear experts. Everyday we work to respond to the growing nuclear science and technology needs of Australia and the world.
Combining scientific expertise with more than $1.3 billion in unique operational assets to provide optimal radioactive waste solutions.
ANSTO offers accelerator-based particle-induced gamma-ray emission techniques to determine total fluorine concentration in a range of solid materials and rapidly screen for the presence of PFAS (perfluoroalkyl and polyfluoroalkyl substances).
To enable the production of nuclear medicine, ANSTO operates manufacturing, processing and distribution facilities in Sydney.
An investment that will secure the long term sustainability of nuclear medicine supply in Australia.
ANSTO drives Australian innovation through partnerships designed to respond to the needs of industry. Get in touch to discuss business opportunities today.
2022 has been a big year for ANSTO with contributions to the advanced manufacturing, space, food, energy industries, and more. As we set our sights on 2023, we thought we’d take the opportunity to share some of our key innovation achievements from this year.
ANSTO seeks candidates who are passionate about making a contribution to Australian society through supporting nuclear science and technology.
University of Melbourne researchers have investigated a method to produce magnetic nanoparticles in Australia for use in COVID-19 PCR tests.
The User Office is the first point of contact for all new and returning facility users accessing ANSTO’s wide range of world-class research infrastructure. These users may be internal ANSTO researchers, external merit researchers, commercial clients, scientific collaborators and partners.
ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program, administered by the Department of Health and Aged Care.
ANSTO announces the recipients of the 2022 organisational awards
The new facility will be built around a product line of ANSTO’s design – a new Technetium-99m generator – that will enable greater process automation than is possible with existing technology, leading to improvements in efficiency, quality and importantly the highest levels of production safety.